Digital Health Validation Lab Evidence Generation Bootcamp

Accelerate your HealthTech solution with our Evidence Generation Bootcamp!

Building on the success of our inaugural bootcamp last year, the Digital Health Validation Lab is proud to host its second edition on Wednesday 1st and Thursday 2nd of October. This two-day, hands-on event is designed for HealthTech innovators who are ready to accelerate their solutions and drive real-world impact.

In today’s fast-moving and competitive HealthTech landscape, robust evidence is critical to achieving regulatory approval, adoption, scale, and long-term success. This bootcamp provides a practical framework to help you confidently navigate the complexities of evidence generation and build a clear, actionable strategy aligned with your innovation and route to market.

💡 Through expert-led sessions, you'll gain:

• Clarity on your evidence requirements and how to address them effectively

• Confidence to engage key stakeholders with timely, relevant evidence and navigate complex evidence demands

• A personalised roadmap for evidence generation, tailored to your solution and market strategy

• Improved understanding of approaches to: Patient and Public Involvement (PPI); concept validation; health economic modelling; simulation; technical feasibility and AI performance testing; clinical investigations for regulatory approval; and clinical and cost-effectiveness studies to support adoption.

Who should attend?

HealthTech startups, SMEs, innovation leads, and academic researchers ready to turn a great solution into an evidence-backed, scalable success.

We’re thrilled to announce our headline speakers, with additional speakers to follow soon.

Olivia Wu

Professor Olivia Wu is a globally recognised authority in Health Technology Assessment (HTA). She holds the prestigious William R Lindsay Chair of Health Economics at the University of Glasgow’s HEHTA and serves as Adjunct Professor at the Faculty of Pharmacy at Mahidol University in Thailand. She is also an elected Fellow of the Royal Society of Edinburgh, reflecting her standing as a trusted voice in health economics and policy.

Professor Wu leads several major NIHR programmes as Director, placing her at the forefront of setting research priorities and advancing evidence-based decision-making across the UK health system.

She has extensive expertise in generating high-quality evidence and translating it into effective healthcare decision-making. Her research spans a broad range of clinical areas and health interventions - including medical devices and digital health - and has directly informed clinical guidelines and health policy at both national and international levels

Neil Hawkins

Professor Neil Hawkins is a Professor of Health Technology Assessment (HTA) at the University of Glasgow, where he brings decades of cross-sector experience to advancing evidence-based healthcare decision-making. His career spans academia, industry, and consultancy, with contributions across pharmacology, clinical development, epidemiology, and HTA.

Before joining academia, Professor Hawkins held senior leadership roles in the private sector, including Vice President of Global Health Economics at ICON PLC and Board Director at Oxford Outcomes Ltd. His interdisciplinary background is supported by postgraduate degrees in pharmacology, health economics, and applied statistics, and he is a Chartered Statistician.

Alongside his academic role, Professor Hawkins serves as a consultant in HTA to the pharmaceutical and medical device industries. He also contributes to national health policy as a member of several NICE committees, including serving as Vice-Chair of the NICE Diagnostics Advisory Committee.

David Lowe

Professor David Lowe is an Emergency Consultant at Queen Elizabeth University Hospital (QEUH), Clinical Director of Innovation at the University of Glasgow, and Clinical Director for Health Innovation for the Scottish Government.

With extensive experience in creating the infrastructure and conditions to translate projects into viable healthcare solutions, Professor Lowe plays a leading role in advancing HealthTech innovation. He is the clinical lead for several initiatives developing and evaluating the deployment of AI and various medical imaging solutions within healthcare systems.

Professor Lowe has also led the development of several impactful digital health tools, such as Lenus COPD and the Trauma App. He is the founder of the EmQuire research group, through which he supports and coordinates quality improvement, innovation, research, and education at QEUH and within its Emergency Department.

Ticket Price TBC

£295.00 - Early Bird Rate (until 15 August 2025, 23.59 BST)

£350.00 - Standard Rate (from 16 August 2025, 00.00 BST)

Please note that registration will close on Friday 19 September, 12.00(BST)